ICD-10-CM Billable Code

J84.115

Respiratory bronchiolitis interstitial lung disease

Clinical Classification Guidelines

Medical Intelligence & Overview

Respiratory bronchiolitis interstitial lung disease (RB-ILD) is a rare type of lung condition characterized by inflammation and scarring of the small airways and surrounding lung tissue. It falls under the broader category of interstitial lung diseases, which involve the interstitial space — the tissue and space around the air sacs of the lungs. Patients with RB-ILD often experience gradual breathing issues, and early diagnosis can help manage the disease effectively. This condition is most commonly associated with smoking but can also be related to other environmental and occupational exposures.

Causes & Symptoms

Clinical Causes: Primary cause linked to cigarette smoking in most cases Long-term exposure to inhaled environmental pollutants or occupational irritants Genetic predispositions, although less common Potential secondary associations with other interstitial lung diseases

Key Symptoms: Persistent cough, often dry Shortness of breath, especially during physical activity Wheezing or a whistling sound when breathing Gradual fatigue and tiredness Unintentional weight loss in advanced cases Chest discomfort or mild chest tightness

Diagnostic & Treatment

Diagnosis Path: Diagnosing RB-ILD involves multiple steps to exclude other lung conditions and confirm inflammation and tissue changes. Typically, it includes: - Medical history review, especially regarding smoking and environmental exposures - Physical examination with listening to lung sounds - Chest imaging, such as high-resolution computed tomography (HRCT), revealing characteristic patterns of lung involvement - Lung function tests, to evaluate breathing capacity and lung volumes - Bronchoscopy with bronchoalveolar lavage or lung biopsy for definitive histopathological diagnosis Because symptoms can mimic other pulmonary diseases, thorough testing is essential for accurate diagnosis.

Treatment Protocols: While there is no cure for RB-ILD, several approaches aim to control symptoms and slow the progression: - Smoking cessation is critically important to prevent further lung damage - Corticosteroids may be prescribed to reduce inflammation in some cases - Avoidance of environmental and occupational exposures that can worsen lung health - Regular monitoring with imaging and lung function tests - Supportive care, including oxygen therapy if breathing becomes significantly impaired - Pulmonary rehabilitation programs to improve physical fitness and breathing efficiency Treatment plans are individualized, often involving a multidisciplinary team to optimize respiratory health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is J84.115 a billable ICD-10 code?
Yes, J84.115 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report J84.115?
Clinical documentation must specify the nature of Respiratory bronchiolitis interstitial lung disease and any associated comorbidities for accurate reporting.

Cite this Clinical Reference